title: Protective effect of mycophenolate mofetil on residual renal function in peritoneal dialysis patients: An open label feasibility study.
abstract: OBJECTIVE
  This study aims to evaluate the safety of mycophenolate mofetil (MMF) and its effect on residual renal function (RRF) during peritoneal dialysis (PD).
  
  
  METHODS
  This is a prospective, randomized study comprising 60 PD patients. The patients were assigned either to the MMF group (MMF dosage: 1.0-1.5 g/day in two divided doses for 6 months, followed by a dose of 0.5-0.75 g/day for another 6 months) or to the control group. The patients close monitoring for 1 year. Variables related to residual renal function, including urine volume, measured glomerular filtration rate (GFR), and renal Kt/V, were measured at four time points.
  
  
  RESULTS
  There were no significant changes in urinary protein excretion in either group (P > 0.05). The MMF group showed a significantly higher urine volume than the control group (955.38 ± 243.54 vs 786.15 ± 279.62 mL/day, P = 0.024). The renal kt/V was also significantly higher in the MMF group (0.59 ± 0.11 in MMF vs 0.50 ± 0.19 in control group, P = 0.032). There was significant difference in the renal measured GFR between the two groups at 6, 9 and 12 months (MMF vs control at 6 months, 6.14 ± 0.66 vs 5.58 ± 0.65 mL/min per 1.73m2, P = 0.003; at 9 months, 5.68 ± 0.80 vs 4.78 ± 0.75, P < 0.001; at 12 months, 5.44 ± 0.91 vs 4.43 ± 0.93, P < 0.001). MMF was well tolerated without any serious complications.
  
  
  CONCLUSIONS
  The use of MMF in PD patients tends to better preserve RRF.
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Xiaoyang
authors: X
authors: Wang
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Xiaoxue
authors: X
authors: Zhang
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Shan
authors: S
authors: Lu
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Dong
authors: D
authors: Liu
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Genyang
authors: G
authors: Chen
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Yanna
authors: Y
authors: Dou
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Wenming
authors: W
authors: Yuan
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Shuang
authors: S
authors: Ma
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Yansheng
authors: Y
authors: Li
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Jing
authors: J
authors: Xiao
authors: Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Nephropathy Research Institutes of Zhengzhou University, Zhengzhou, China.
authors: Zhanzheng
authors: Z
authors: Zhao
mesh_terms: D000328:Adult; D005240:Feasibility Studies; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007668:Kidney / Q000187:drug effects* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000009:adverse effects / Q000494:pharmacology*; D010530:Peritoneal Dialysis; D011446:Prospective Studies
chemical_list: D009173:Mycophenolic Acid
keywords: mycophenolate mofetil; peritoneal dialysis; residual renal function